525.35
2.04%
Axis Direct
We expect the whole API industry to continue facing challenges due to a fall in realization as well as an increase in cost pressure. We foresee the situation to continue for the next 2-3 quarters and therefore recommend a HOLD rating on the stock with the target price of Rs 1,300/share.
Promoters pledged 5.53% of shares in last quarter. Total pledge stands at 31.57% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended